WeVote

Bill

Bill

HJR 11

Joint Resolution Recognizing Neonatal Abstinence Syndrome

2026 General Session Introduced by Emily Buss and 1 co-sponsor

Utah legislature formally recognizes Neonatal Abstinence Syndrome as a public health issue but takes no binding action or funding measures.

House/ 1st reading (Introduced)
0
WeVote Research Nonpartisan
Bill Summary · HJR 11

Legislative bill overview

HJR 11 is a joint resolution that recognizes Neonatal Abstinence Syndrome (NAS)—a condition affecting newborns exposed to opioids or other substances in utero. Joint resolutions are ceremonial measures that express legislative sentiment rather than create binding law or allocate funds. The bill appears designed to raise awareness and official acknowledgment of this public health issue in Utah.

Why is this important

NAS affects hundreds of infants annually in the United States and requires specialized medical care, extended hospitalizations, and long-term monitoring. Official legislative recognition can elevate public awareness, potentially influence policy priorities, and signal state commitment to addressing substance use disorders in pregnant populations and their health consequences. However, recognition alone does not fund treatment programs or change regulatory requirements.

Potential points of contention

  • Symbolic vs. substantive action: Critics may argue a resolution is performative and doesn't allocate resources or mandate concrete interventions to address NAS prevention and treatment
  • Scope of substance use policy: The resolution's framing could become contentious depending on whether it emphasizes criminalization, treatment access, or harm reduction approaches to maternal substance use
  • Budget implications: While joint resolutions typically have minimal fiscal cost, stakeholders may debate whether recognition should trigger funded legislative action on NAS-related healthcare or support services

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.